Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+immunologic neighborhoods containing NK cells, T cells and macrophages

被引:2
|
作者
Nersesian, Sarah [1 ,2 ]
Arseneau, Riley J. [2 ,3 ]
Mejia, Jorge P. [1 ,2 ]
Lee, Stacey N. [1 ,2 ]
Westhaver, Lauren P. [3 ]
Griffiths, Nigel W. [3 ]
Grantham, Stephanie R. [2 ]
Meunier, Liliane [4 ,5 ]
Communal, Laudine [4 ,5 ]
Mukherjee, Avik [6 ]
Mes-Masson, Anne-Marie [4 ,7 ]
Arnason, Thomas [3 ,8 ]
Nelson, Brad H. [9 ,10 ,11 ]
Boudreau, Jeanette E. [1 ,2 ,3 ]
机构
[1] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada
[2] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada
[4] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
[5] Inst Canc Montreal, Montreal, PQ, Canada
[6] Akoya Biosci, Menlo Pk, CA USA
[7] Univ Montreal, Dept Med, Montreal, PQ, Canada
[8] QEII Hlth Sci Ctr, Dept Pathol & Lab Med, Nova Scotia Hlth Cent Zone, Halifax, NS, Canada
[9] British Columbia Canc Res Inst, Deeley Res Ctr, Victoria, BC, Canada
[10] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada
[11] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
加拿大健康研究院;
关键词
natural killer (NK) cell; ovarian cancer; high grade serous cancer; spatial biology; CD16A; NATURAL-KILLER-CELLS; ANTITUMOR-ACTIVITY; IN-VIVO; LYMPHOCYTES; ENGAGER; SAFETY;
D O I
10.3389/fimmu.2023.1307873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background For patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These observations highlight a gap in the understanding of how the immune system functions and interacts within HGSC tumors.Methods We analyzed duplicate core samples from 939 patients with HGSC to understand patterns of immune cell infiltration, localization, and associations with clinical features. We used high-parameter immunohistochemical/Opal multiplex, digital pathology, computational biology, and multivariate analysis to identify immune cell subsets and their associations with HGSC tumors.Results We defined six patterns of cellular infiltration by spatially restricted unsupervised clustering of cell subsets. Each pattern was represented to some extent in most patient samples, but their specific distributions differed. Overall (OS) and progression-free survival (PFS) corresponded with higher infiltration of CD16a+ cells, and their co-localization with macrophages, T cells, NK cells, in one of six cellular neighborhoods that we defined with our spatial assessment.Conclusions Immune cell neighborhoods containing CD16a+ cells are associated with improved OS and PFS for patients with HGSC. Patterns of immunologic neighborhoods differentiate patient outcomes, and could inform future, more precise approaches to treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
    L. C. Hanker
    A. El-Balat
    Z. Drosos
    S. Kommoss
    T. Karn
    U. Holtrich
    G. Gitas
    M. Graeser-Mayer
    M. Anglesio
    D. Huntsman
    A. Rody
    H. Gevensleben
    F. Hoellen
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1421 - 1430
  • [2] Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
    Hanker, L. C.
    El-Balat, A.
    Drosos, Z.
    Kommoss, S.
    Karn, T.
    Holtrich, U.
    Gitas, G.
    Graeser-Mayer, M.
    Anglesio, M.
    Huntsman, D.
    Rody, A.
    Gevensleben, H.
    Hoellen, F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1421 - 1430
  • [3] Targeting macrophages and regulatory T cells improves response to chemotherapy in high-grade serous ovarian cancer
    Elorbany, Samar
    Berlato, Chiara
    Carnevalli, Larissa
    Barry, Simon
    Maniati, Eleni
    Wang, Jun
    Manchanda, Ranjit
    Kzhyshkowska, Julia
    Balkwill, Frances
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer
    Elorbany, Samar
    Berlato, Chiara
    Carnevalli, Larissa
    Maniati, Eleni
    Wang, Jun
    Barry, Simon
    Manchanda, Ranjit
    Kzhyshkowska, Julia
    Balkwill, Frances
    CANCER RESEARCH, 2023, 83 (08)
  • [5] High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
    Corvigno, Sara
    Mezheyeuski, Artur
    De La Fuente, Laura Martin
    Westbom-Freme, Sofia
    Carlson, Joseph W.
    Fernebro, Josefin
    Avall-Lundqvist, Elisabeth
    Kannisto, Paivi
    Hedenfalk, Ingrid
    Malander, Susanne
    Rolny, Charlotte
    Dahlstrand, Hanna
    Ostman, Arne
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 860 - 868
  • [6] T-cell activation is associated with high-grade serous ovarian cancer survival
    Wang, Lei
    Sun, Wenjie
    Zhang, Guoan
    Huo, Jingrui
    Tian, Yi
    Zhang, Yan
    Yang, Xiaohui
    Liu, Yingfu
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (08) : 2189 - 2197
  • [7] Developing uPAR CAR T Cells for High-Grade Serous Ovarian Cancer
    Zhang, Zeda
    Fang, Xin
    Ho, Yu-Jui
    Haubner, Sascha
    Kogel, Friederike
    Hinterleitner, Clemens
    Paffenholz, Stella
    Chen, Kevin
    Luan, Wei
    Kulick, Amanda
    Gunset, Gertrude
    Angus, Andreina Garcia
    Zhang, Jing
    Xu, Zijian
    Wang, Adam
    Jiang, Qingwen
    De Stanchina, Elisa
    Weigelt, Britta
    Zamarin, Dmitriy
    Filliol, Aveline
    Feucht, Judith
    Mansilla-Soto, Jorge
    Amor, Corina
    Sadelain, Michel
    Lowe, Scott
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high-grade serous ovarian cancer
    Zhang, Guodong
    Xu, Qing
    Zhang, Xiangyun
    Yang, Moran
    Wang, Yiying
    He, Mengdi
    Lu, Jiaqi
    Liu, Haiou
    CANCER MEDICINE, 2021, 10 (12): : 3905 - 3918
  • [9] A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
    Millstein, Joshua
    Budden, Timothy
    Anglesio, Michael
    Talhouk, Aline
    Beeghly-Fadiel, Alicia
    Berchuck, Andrew
    Chenevix-Trench, Georgia
    deFazio, Anna
    Fasching, Peter A.
    Gayther, Simon
    Garcia, Maria
    Goode, Ellen L.
    Henderson, Michelle
    Konecny, Gottfried E.
    Orsulic, Sandra
    Huntsman, David
    Bowtell, David
    Doherty, Jennifer
    Pharoah, Paul
    Ramus, Susan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
    Zhang, Jie
    He, Tianhui
    Yin, Zhongnan
    Shang, Chunliang
    Xue, Lixiang
    Guo, Hongyan
    FRONTIERS IN ONCOLOGY, 2022, 12